(111 days)
No
The summary describes a mechanical implant made of Nitinol for bone fixation and does not mention any software, algorithms, or data processing that would indicate the use of AI or ML.
No
The device is an implant for bone fixation used in surgery, which falls under the category of orthopedic devices rather than therapeutic devices that treat a disease or condition.
No
This device is a Nitinol implant for bone fixation and is used in surgical procedures; it does not diagnose medical conditions.
No
The device description explicitly states it is a Nitinol implant for bone fixation, which is a physical hardware component.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a device for surgical fixation of bone fractures and osteotomies. This is a direct surgical intervention on the body.
- Device Description: The device is described as a Nitinol implant designed to be placed within the body to hold bone fragments together.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens in vitro (outside the body) to provide information about a physiological state, health, or disease. IVDs typically involve analyzing blood, urine, tissue samples, etc.
The device described is a surgical implant, which falls under a different regulatory category than IVDs.
N/A
Intended Use / Indications for Use
- Fracture and osteotomy fixation and joint arthrodesis of the hand and foot.
- Fixation of proximal tibial metaphysis osteotomy.
- Fixation of small fragments of bone (i.e. small fragments of bone which are not comminuted to the extent to preclude staple placement). These fragments may be located in long bones such as the femur, fibula and tibia in the lower extremities; the humerus, ulna or radius in the upper extremities; the clavicle and ribs; and in flat bone such as the pelvis, scapula and sternum.
Product codes
JDR
Device Description
The Elite™ Nitinol Fixation System, like primary predicate Speed Titan™ K133780, is a Nitinol implant for bone fixation and is designed to be delivered to the operating room in an "open" (legs parallel) and constrained state. The Elite™ Nitinol Fixation System was designed for surgeons who desire additional fixation points for increased rotational stability. The implant does not require any external heating. The implant is fully active at room and body temperature so that the legs compress after release from instrument (additional legs in Straight design compress in tandem).
The primary differences between the Elite™ Nitinol Fixation System and the cleared Speed Titan™ K133780 are the configurations featured. The Speed Titan™ K133780 is a staple with two legs, while the Elite™ Nitinol Fixation System introduces three configurations: a Straight (with two and four legs), a Y-shape (three and four legs) and an H-shape (four legs).
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Hand, Foot, Proximal Tibial Metaphysis, Femur, Fibula, Tibia, Humerus, Ulna, Radius, Clavicle, Ribs, Pelvis, Scapula, Sternum
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Surgeons / Operating Room
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Performance testing includes: Corrosion (ASTM F2129-08), Elastic Static Bending (ASTM F564-10, A4) Pull-out Fixation Strength (ASTM F564-10, A2) and MR Compatibility (ASTM F2052, ASTM F2213, ASTM F2119, ASTM F2182) results of which demonstrate substantial equivalence or better.
Key Metrics
Not Found
Predicate Device(s)
Speed Titan™ (formerly cleared as Speed XL K133780)
Reference Device(s)
OSSplate™ (formerly cleared as Memograph Staple System K993714), Speed Triad™ (K133844)
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3030 Single/multiple component metallic bone fixation appliances and accessories.
(a)
Identification. Single/multiple component metallic bone fixation appliances and accessories are devices intended to be implanted consisting of one or more metallic components and their metallic fasteners. The devices contain a plate, a nail/plate combination, or a blade/plate combination that are made of alloys, such as cobalt-chromium-molybdenum, stainless steel, and titanium, that are intended to be held in position with fasteners, such as screws and nails, or bolts, nuts, and washers. These devices are used for fixation of fractures of the proximal or distal end of long bones, such as intracapsular, intertrochanteric, intercervical, supracondylar, or condylar fractures of the femur; for fusion of a joint; or for surgical procedures that involve cutting a bone. The devices may be implanted or attached through the skin so that a pulling force (traction) may be applied to the skeletal system.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name in a circular arrangement around a symbol. The symbol consists of three stylized human profiles facing to the right, representing the department's focus on health and human well-being. The profiles are depicted in a simple, abstract manner.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
BioMedical Enterprises, Incorporated Mr. Joe W. Soward Director, Quality, Compliance and Regulatory Affairs 14785 Omicron Drive, Suite 205 San Antonio, Texas 78245
May 11, 2015
Re: K150125 Trade/Device Name: Elite™ Nitinol Fixation System Regulation Number: 21 CFR 888.3030 Regulation Name: Single/multiple component metallic bone fixation appliances and accessories Regulatory Class: Class II Product Code: JDR Dated: April 8, 2015 Received: April 13, 2015
Dear Mr. Soward:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing
1
(21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled. "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson -S
Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K150125
Device Name Elite™ Nitinol Fixation System
Indications for Use (Describe)
· Fracture and osteotomy fixation and joint arthrodesis of the hand and foot.
• Fixation of proximal tibial metaphysis osteotomy.
· Fixation of small fragments of bone (i.e. small fragments of bone which are not comminuted to the extent to preclude staple placement). These fragments may be located in long bones such as the femur, fibula and tibia in the lower extremities; the humerus, ulna or radius in the upper extremities; the clavicle and ribs; and in flat bone such as the pelvis, scapula and sternum.
| Type of Use (Select one or both, as applicable) |
|---|
| ------------------------------------------------- |
For activities ID at 30 CFR 900 Subchapter D
For Coal Combustion Residuals (CCR)
X Prescription Use (Part 21 CFR 801 Subpart D)
| | Over-The-Counter Use (21 CFR 801 Subpart C)
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image shows the logo for BioMedical Enterprises. The logo consists of a stylized graphic of three connected shapes that resemble staples with sharp points. Below the graphic, the words "BioMedical Enterprises" are written in a sans-serif font, with "BioMedical" in a slightly larger font size and a different color than "Enterprises".
510(K) Summary
In accordance with the Food and Drug Administration Rule to implement provisions of the Safe Medical Devices Act of 1990 and in conformance with 21 CFR 807.92, this information serves as a Summary of Safety and Effectiveness for the use of the Elite™ Nitinol Fixation System.
| | 1. Submitted By: | BioMedical Enterprises, Inc.
14785 Omicron Dr., Suite 205
San Antonio, TX 78245 |
|--|------------------------------------|----------------------------------------------------------------------------------------------------------------|
| | Date: | May 4, 2015 |
| | Contact Person: | Joe Soward
Director Quality Compliance and Regulatory Affairs
Office: 210-881-0011
Fax: 210-677-0355 |
| | 2. Proprietary Name: | Elite™ Nitinol Fixation System |
| | Common Name: | Bone Staple |
| | Classification Name and Reference: | Single/multiple component metallic bone fixation
appliances and accessories
(21 CFR 888.3030 – Class II) |
| | Device Product Code, Device Panel: | JDR - Orthopedic |
| | | |
| | 3. Primary Predicate: | Speed Titan™ (formerly cleared as Speed XL K133780) |
| | Reference Devices: | OSSplate™ (formerly cleared as Memograph Staple
System K993714), Speed Triad™ (K133844) |
4. Device Description:
The Elite™ Nitinol Fixation System, like primary predicate Speed Titan™ K133780, is a Nitinol implant for bone fixation and is designed to be delivered to the operating room in an "open" (legs parallel) and constrained state. The Elite™ Nitinol Fixation System was designed for surgeons who desire additional fixation points for increased rotational stability. The implant does not require any external heating. The implant is fully active at room and body temperature so that the legs compress after release from instrument (additional legs in Straight design compress in tandem).
The primary differences between the Elite™ Nitinol Fixation System and the cleared Speed Titan™ K133780 are the configurations featured. The Speed Titan™ K133780 is a staple with two legs, while the Elite™ Nitinol Fixation System introduces three configurations: a Straight (with two and four legs), a Y-shape (three and four legs) and an H-shape (four legs).
4
Image /page/4/Picture/0 description: The image shows the logo for BioMedical Enterprises. The logo consists of a stylized gray symbol that resembles a series of interconnected staples or brackets with pointed ends. Below the symbol, the words "BioMedical Enterprises" are written in an orange sans-serif font. The overall design is clean and modern.
-
- Intended Use
The Elite™ Nitinol Fixation System is indicated for fracture and osteotomy fixation and joint arthrodesis of the hand and foot. Fixation of proximal tibial metaphysis osteotomy. Fixation of small fragments of bone (i.e. small fragments of bone which are not comminuted to the extent to preclude staple placement). These fragments may be located in long bones such as the femur, fibula and tibia in the lower extremities; the humerus, ulna or radius in the upper extremities; the clavicle and ribs; and in flat bone such as the pelvis, scapula and sternum.
- Intended Use
-
- Technological Characteristics Comparison
The Speed Titan™ K133780 was originally cleared as Speed XL in K133780. It was introduced in two sizes and featured a wide. flat bridge dimension for use in midfoot/hindfoot procedures. The Speed Titan™ K133780 was additionally cleared as part of bundle submission K142292 which expanded its indications for use and size offerings.
- Technological Characteristics Comparison
The Elite™ Nitinol Fixation System and primary predicate Speed Titan™ K133780 share the same technological characteristics. More specifically, they share the same indications and intended use and are both fabricated from nitinol. following same manufacturing procedures. The only modifications to the device involve changes in geometry related to number of legs, legs, width, and implant shapes (Straight, Y-shape and H-shape). The straight shape configurations are similar in shape to the Speed Titan™ K133780. The Y-shape and H-shape configurations are similar in shape to the reference Speed Triad™ K133844 and OSSplate™ K993714, respectively.
-
- Substantial Equivalence Non-Clinical Evidence
Performance testing includes: Corrosion (ASTM F2129-08), Elastic Static Bending (ASTM F564-10, A4) Pull-out Fixation Strength (ASTM F564-10, A2) and MR Compatibility (ASTM F2052, ASTM F2213, ASTM F2119, ASTM F2182) results of which demonstrate substantial equivalence or better.
- Substantial Equivalence Non-Clinical Evidence
-
- Substantial Equivalence Clinical Evidence N/A
-
- Substantial Equivalence Conclusions
The design characteristics of the subject devices do not raise any new types of questions regarding safety or effectiveness. From the evidence submitted in this 510(k), the subject devices can be expected to perform at least as well as the predicate systems and are substantially equivalent. The safety and effectiveness of the Elite™ Nitinol Fixation System is adequately supported by testing, substantial equivalence information, materials information and comparison of design characteristics provided within this premarket submission.